Voyager Therapeutics Inc

Stock Chart, Company Information, and Scan Results

$5.16(as of Oct 9, 3:59 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Voyager Therapeutics Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$5.16
Ticker SymbolVYGR
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees172
CountyUSA
Market Cap$292.9M
EBIDTA-118.9M
10-Day Moving Average4.83
P/E Ratio-2.80
20-Day Moving Average4.53
Forward P/E Ratio0.00
50-Day Moving Average3.95
Earnings per Share-1.86
200-Day Moving Average3.93
Profit Margin-641.96%
RSI66.80
Shares Outstanding55.5M
ATR0.34
52-Week High8.28
Volume1,021,700
52-Week Low2.65
Most Recent Support Level4.60
Book Value243.9M
Most Recent Resistance Level5.06
P/B Ratio1.24
Upper Keltner5.29
P/S Ratio7.10
Lower Keltner3.77
Debt-to-Equity Ratio5.29
Next Earnings Date11/18/2025
Cash Surplus2.0M
Next Ex-Dividend DateUnknown

Voyager Therapeutics, Inc., a biotechnology company, focuses on the human genetics for the cure of neurological diseases. The company's lead product candidate is VY7523, an anti-tau antibody program for the treatment of alzheimer's disease (AD). Its product pipeline includes VY1706, a tau silencing gene therapy in preclinical trial for the treatment of alzheimer's disease; SOD1 silencing gene therapy program for treating amyotrophic lateral sclerosis in preclinical trial; and vectorized anti-amyloid antibody early research program for the treatment of AD in preclinical trial. The company is also developing VY-FXN01 for treating friedreich's ataxia; and GBA1 gene replacement program to treat parkinson's disease. In addition, it provides research program for the treatment of Huntington's disease. The company has collaboration and license agreements with Alexion; AstraZeneca Ireland Limited; Novartis Pharma AG; and Neurocrine Biosciences, Inc. for the treatment of various other diseases of the central nervous system. Voyager Therapeutics, Inc. was incorporated in 2013 and is headquartered in Lexington, Massachusetts.

Voyager Therapeutics Inc In Our Stock Scanner

As of Oct 10, 2025
example chart graphic
Scan Name: Low Debt to Equity RatioScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Uptrending StocksScan Type: Chart Pattern Scans
As of ---
example chart graphic
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Golden CrossScan Type: Stock Indicator Scans
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.